DIMENSIONAL FUND ADVISORS LP - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$39,936,817
+0.0%
879,801
+23.7%
0.01%0.0%
Q2 2023$39,935,439
+16.2%
711,271
-6.4%
0.01%
+8.3%
Q1 2023$34,359,485
+108998.5%
759,735
-1.9%
0.01%
+33.3%
Q4 2022$31,494
-99.9%
774,811
+19.4%
0.01%
-43.8%
Q3 2022$42,414,000
+58.6%
649,060
+47.5%
0.02%
+60.0%
Q2 2022$26,738,000
+77.5%
439,926
+83.3%
0.01%
+100.0%
Q1 2022$15,067,000
-23.3%
239,987
-7.4%
0.01%
-16.7%
Q4 2021$19,636,000
+13.4%
259,041
+67.5%
0.01%0.0%
Q3 2021$17,311,000
-26.6%
154,670
+6.1%
0.01%
-14.3%
Q2 2021$23,584,000
+39.6%
145,822
+5.1%
0.01%
+16.7%
Q1 2021$16,897,000
+2.4%
138,750
+28.9%
0.01%0.0%
Q4 2020$16,496,000
+94.0%
107,647
+5.9%
0.01%
+50.0%
Q3 2020$8,505,000
+14.5%
101,657
+0.6%
0.00%
+33.3%
Q2 2020$7,425,000
+97.8%
101,012
+14.2%
0.00%
+50.0%
Q1 2020$3,754,000
+32.5%
88,485
+90.2%
0.00%
+100.0%
Q4 2019$2,834,00046,5330.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 508,558$82,330,00027.28%
Valiant Capital Management, L.P. 307,700$49,814,0003.74%
NEA Management Company, LLC 1,590,002$257,405,0003.35%
NIA IMPACT ADVISORS, LLC 39,891$6,458,0003.15%
Ikarian Capital, LLC 200,000$32,379,0002.62%
Soleus Capital Management, L.P. 103,114$16,693,0002.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 157,334$25,471,0002.47%
Capital Impact Advisors, LLC 45,440$7,356,0002.37%
ARK Investment Management 7,776,119$1,258,876,0002.34%
Sassicaia Capital Advisers LLC 13,513$2,188,0002.28%
View complete list of CRISPR THERAPEUTICS AG shareholders